Cite

    P. Conaghan et al.. “An intra-articular, extended release formulation of triamcinolone (FX006) affords clinically relevant improvements in pain and function of knee osteoarthritis: post-hoc pooled analyses of 3 randomized controlled trials.” Osteoarthritis and cartilage, vol. 25, n.d., pp. S432–S433. http://access.bl.uk/ark:/81055/vdc_100045519110.0x00004b